BSESkybiotech Healthcare LtdMinimalNeutral
Announced Thu, 9 Apr · 11:36 IST

Certificate under Reg. 74(5) of SEBI (DP) Regulation, 2018 received from RTA

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
1-day move
₹146.20
prior close
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-5.0-5.0-5.0+27.2+10.5
Up moveDown movePending
AI summary

Skybiotech Healthcare Ltd has submitted a routine quarterly compliance certificate from its Registrar and Share Transfer Agent (RTA), Satellite Corporate Services Pvt. Ltd., for the quarter ended 31st March 2026. Under SEBI's Reg. 74(5), the RTA must confirm the status of physical share certificates received for dematerialization each quarter. In this case, the RTA has confirmed that no physical share certificates were received from shareholders for conversion into demat form during the quarter. The filing is signed by Managing Director Poonam Prakash Rathi.

Likely market impact

This is a standard procedural compliance filing with no material impact on shareholders or the stock price. It simply confirms zero activity in physical-to-demat conversions during the quarter and reflects routine corporate governance disclosure.